Evidence map›Paper›PMID 40469251›Full record

ArticlePreventive medicine reports2025

Characteristics of persons with multiple sclerosis covered by public drug insurance in a Quebec Birth Cohort.

Yasmine Sadou, Miceline Mésidor, Marie-Claude Rousseau

Abstract read
In one paragraph

Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yasmine SadouCentre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique (INRS), Laval, Canada.
Miceline MésidorCentre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique (INRS), Laval, Canada.
Marie-Claude RousseauCentre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique (INRS), Laval, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: People living with multiple sclerosis use medications for several indications, but little is known about their prescription drug use in Quebec, notably because the public drug insurance covers only part of the population. We compared the characteristics of those with public drug insurance to those privately covered. Methods: In a cohort of persons born in 1970-1974, we identified those living with multiple sclerosis by applying a validated algorithm to administrative health data. Individuals with public coverage were those who had at least one covered period after their date of diagnosis between January 1, 1997, and December 31, 2014. We used descriptive statistics to compare sociodemographic and healthcare utilization characteristics by type of coverage. Results: Among the 1363 persons living with multiple sclerosis, 720 (53 %) were covered by the public drug insurance. Individuals with public drug coverage were younger, more likely to be materially and socially deprived, and had a lower median income than those with private insurance, but otherwise had similar sociodemographic characteristics. The proportion of people who had at least one multiple sclerosis-related visit to a general practitioner (39 % versus 45 %) and hospitalization (6 % versus 3 %) differed among those with public compared to private coverage. However, the utilization of other health services, including neurologist consultations, did not differ by type of drug coverage. Conclusion: People with multiple sclerosis covered by the public and private drug insurance differed in terms of age, income, deprivation, multiple sclerosis-related visits to a general practitioner and hospitalizations, but not neurologist consultations.

Indexed as

Administrative dataCharacteristicsMultiple sclerosisPublic drug coverageQuebec

Identifiers

PMID40469251
PMCPMC12135425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.